Tranexam pills 250mg №10

Active ingredient and dosage form

Tranexam coated tablets:
1 tab. contains tranexamic acid 250 mg,
Excipients: the core is MCC, hydroxypropyl cellulose, sodium starch glycolate, talc, Calcium stearate, aerosil;
shell - hypromellose, titanium dioxide, talc, polyethylene glycol 6000;
Pack of 10, 20, 30 or 50;

Tranexam intravenous solution:
1 l contains tranexamic acid 50 g;
Excipients: water for injection up to 1 l;
in a package of 5 or 10 ampoules (with 5 ml of solution).

Mechanism of action

Tranexam has hemostatic, anti-inflammatory, anti-allergic effect.

Indications and usage

Common to both dosage forms Tranexam: bleeding or the risk of bleeding due to increased fibrinolysis, as generalized (bleeding during operations and in the postoperative period, postpartum hemorrhage, manual separation of the afterbirth, chorionic detachment, bleeding during pregnancy, malignant tumors of the pancreas and prostate glands, hemophilia, hemorrhagic complications, fibrin arrhythmias, fibrin arteries, hemorrhagic complications, hysterologic fibrinoscopy purpura, leukemia, liver disease, previous therapy with streptokinase), and local (uterine, nasal, pulmonary, w ludochno Gastrointestinal bleeding, hematuria, bleeding after prostatectomy, conization about carcinoma, tooth extraction in patients with hemorrhagic diathesis).
For Tranexam pills in addition:
hereditary angioedema;
allergic diseases (eczema, allergic dermatitis, urticaria, drug and toxic rash);
inflammatory diseases (tonsillitis, pharyngitis, laryngitis, stomatitis) and aphthae of the oral mucosa.
For solution for intravenous administration in addition:
surgical intervention on the bladder;
surgical procedures for systemic inflammatory reaction (sepsis, peritonitis, pancreatonecrosis, severe and moderate severity of preeclampsia, shock of various etiologies, and other critical conditions).

Contraindications

hypersensitivity to Tranexam;
subarachnoid hemorrhage.
Carefully:
thrombosis (cerebral thrombosis, myocardial infarction, thrombophlebitis) or the threat of their development;
thrombohemorrhagic complications (in combination with Heparin and indirect anticoagulants);
violation of color vision;
hematuria from the upper urinary tract (possible obstruction of a blood clot);
renal failure (cumulation possible).

Adverse reactions

Common to both dosage forms: nausea, vomiting, heartburn, diarrhea, rash, itching, loss of appetite, drowsiness, dizziness may occur. There may be a violation of color vision, rarely - thrombosis, thromboembolism.
For solution for intravenous administration in addition: urticaria, weakness, drowsiness, tachycardia, chest pain, hypotension (with a rapid on / in the introduction), blurred vision.

Dosage and administration

Tranexam is taken internally (regardless of food intake), 250–500 mg 3–4 times a day. In / in, slowly, 10-15 ml. The maximum daily dose is 2 g. When removing teeth in patients with hemophilia: before the operation, simultaneously with the start of replacement therapy, it is introduced into / in a dose of 10 mg / kg; after surgery, by mouth 25 mg / kg 3-4 times per day for 2–8 days or by mouth at a dose of 25 mg / kg 3-4 times per day, starting 1 day before the upcoming operation. Immediately before the / in the introduction of diluted in standard infusion solutions, dextran, aminocaproic acid solution.

Store in a cool and dark place, protected from light and moisture, at a temperature not higher than 25 ° C.